Company Profile
LiTTLE-PA life science company limited ( LiTTLE-PA lifescience) was founded in 2014 by Dr Xin hua Gu from Chinese Academy of Sciences and located in Wuhan Huagong technology business incubator . We are a science and technology company which mainly engaged in the biological and pharmaceutical industry . Since our company establishment, We have been granted generous financial support form all levels of provincial, municipal and district and are moving forward to a mature biological high-tech enterprises. Our company business mainly involves in biochemistry, molecular biology, biomedical engineering, advanced nano-materials and related biotechnological areas of product research, development, sale, transfer, technical consultation , technical services. We are focusing on independent innovation and the core intellectual property of science and technology , Our company has also specially developed fluorescence labeling and spin labeling products applied to proteins ,nucleic acids and some other biological macromolecules . We will provide our excellent service to the majority of developers engaged in bio medicine with much higher quality and more reasonable price .
VIEW MORE VIEW LESSProduct List
| Product Name | Synonyms | CAS No. | Grate/Content | Operate |
|---|---|---|---|---|
5-Chloroacetamido-2-methylene-1,3,3-trimethylindoline |
5-CHLOROACETAMIDO-2-METHYLENE-1,3,3-TRIMETHYLINDOLINE;2-Chloro-N-(2,3-dihydro-1,3,3-triMethyl-2-Methylene-1H-indol-5-yl)acetaMide;acetaMide, 2-chloro-N-(2,3-dihydro-1,3,3-triMethyl-2-Methylene-1H-indol-5-yl) |
51980-53-1 | Inquiry | |
Fitc Fluorescein Isothiocyanate |
Spiro[isobenzofuran-1(3H),9′-[9H]xanthen]-3-one,3′,6′-dihydroxy-5(or 6)-isothiocyanato-;Fluorescein,isothiocyanato-;3′,6′-Dihydroxy-5(or 6)-isothiocyanatospiro[isobenzofuran-1(3H),9′-[9H]xanthen]-3-one;FITC;Fluorescein isothiocyanate;71: PN: WO2016072662 SEQID: 71 claimed sequence;28325-37-3;29792-10-7;64937-10-6;15042-94-1 |
27072-45-3 | Inquiry | |
Nmr Contrast Agent, Gd-Dtpabma |
Gadolinium,[5,8-bis[(carboxy-κO)methyl]-11-[2-(methylamino)-2-(oxo-κO)ethyl]-3-(oxo-κO)-2,5,8,11-tetraazatridecan-13-oato(3-)-κN5,κN8,κN11,κO13]-;Gadolinium,[5,8-bis(carboxymethyl)-11-[2-(methylamino)-2-oxoethyl]-3-oxo-2,5,8,11-tetraazatridecan-13-oato(3-)]-;2,5,8,11-Tetraazatridecan-13-oic acid,5,8-bis(carboxymethyl)-11-[2-(methylamino)-2-oxoethyl]-3-oxo-,gadolinium complex;[5,8-Bis[(carboxy-κO)methyl]-11-[2-(methylamino)-2-(oxo-κO)ethyl]-3-(oxo-κO)-2,5,8,11-tetraazatridecan-13-oato(3-)-κN5,κN8,κN11,κO13]gadolinium;S 041;Gadolinium-DTPA-BMA;Gd DTPA-BMA;Gadodiamide;DV 7572 |
131410-48-5 | Inquiry |